The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

The Point of Care (POC) Celltrion DiaTrust COVID-19 Ag Rapid Test is intended to detect the presence of SARS-CoV-2, the virus that causes COVID-19, based on a nasopharyngeal (deep inside the nose to the back of the throat) swab sample from patients. The sample is collected by healthcare providers.

Celltrion USA is recalling the affected POC DiaTrust COVID-19 Ag Rapid Test because it may have been distributed to unauthorized users. This test is authorized for use only by laboratories with CLIA certification and a corresponding CLIA Certificate Number (CCN). CLIA-certified laboratories must meet specific criteria that qualify them to perform diagnostic tests. Emergency use of these tests is limited to authorized laboratories and use of these tests in unauthorized settings (for example, customers without CLIA -certification) may present an increased risk of false results as the persons performing these tests may not have the qualifications or training to properly and safely administer them.

Although there have been no reports of injuries, adverse health consequences, or death associated with the use of these affected products, false positive or false negative results from improper use of these tests could lead to further exposure of uninfected individuals to SARS-CoV-2 virus. There are also serious injury risks if someone who is not trained to collect a nasopharyngeal swab sample attempts to do so.

On April 5, 2022, Celltrion USA notified customers about this issue by email and instructed them to provide a CLIA Certificate Number and contact information to their distributor.

Customers without CLIA certification were instructed to:

Customers with questions or concerns about this recall may contact their distributors or Celltrion USA at celltrionusa.CS@celltrion.com.

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.